Found: 1
Select item for more details and to access through your institution.
Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 153, doi. 10.1111/1759-7714.13736
- By:
- Publication type:
- Article